Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 799

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 799
---
 that each Buyer has independently participated with the BC Entities in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose. The use of a single agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of the BC Parties, not the action or decision of any Buyer, and was done solely for the convenience of the BC Entities and not because it was required or requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between applicable BC Entities and a Buyer, solely, and not between the Company, its Subsidiaries and the Buyers collectively and not between and among the Buyers.

<div align='center'>[signature pages follow]

B-38</div>

TABLE OF CONTENTS

IN WITNESS WHEREOF, each Buyer, the Target and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

| COMPANY:                         |     |                                                            |
| CHANNEL THERAPEUTICS CORPORATION |     |                                                            |
| By:                              |     | /s/ Francis Knuettel II                                    |
|                                  |     | Name: Francis Knuettel II                                  |
|                                  |     | Title: Chief Executive Officer and Chief Financial Officer |

B-39

TABLE OF CONTENTS

IN WITNESS WHEREOF, each Buyer, the Target and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

| TARGET:   |     |                                                     |
| LNHC INC. |     |                                                     |
| By:       |     | /s/ Richard Baxter                                  |
|           |     | Name: Richard Baxter                                |
|           |     | Title: Senior Vice President, Investment Operations |

B-40

TABLE OF CONTENTS

IN WITNESS WHEREOF, each Buyer, the Target and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

| BUYER:  |     |                     |
| [BUYER] |     |                     |
| By:     |     |                     |
|         |     | Name:               |